Analysis of Pharmaceuticals by Capillary Electrophoresis
Kevin D. Altria
2013. g. apr. · CHROMATOGRAPHIA CE-Series 2. grāmata · Springer Science & Business Media
E-grāmata
285
Lappuses
reportAtsauksmes un vērtējumi nav pārbaudīti. Uzzināt vairāk
Par šo e-grāmatu
During the 1980's the analysis of pharmaceuticals was dominated by the use of High Perfor mance Liquid Chromatography (HPLC). Other separative techniques such as Gas Chromato graphy and Thin Layer Chromatography offered alternatives but their quantitative capabili ties and/or solute range could not approach that of HPLC. The majority of pharmaceuticals are ionic and it would be reasonable to assume that electrophoresis may be useful in the analysis of pharmaceuticals. However, the electrophore tic instruments available in the 1980's were labour intensive and employed post-separation detection procedures. During the late 1980's and early 1990's extensive research was con ducted into the possibilities of conducting electrophoretic separations in capillaries. This approach allowed on-line detection and could be performed on fully automated equipment. This research led to the advent of modern day capillary electrophoresis (CE) instruments which offer similar performance and automation levels to that of HPLC. Research was also focused on developing applications for CE and particular attention was paid to applications within the pharmaceutical analysis area. These applications proved that CE could be applied to a wide range of drug types including water insoluble and neutral compounds. The ability to achieve efficient chiral separations of drugs also increased the popularity of the technique. CE with indirect UV detection has become established as a simple and effective alternative to ion-exchange chromatography for the determination of small inorganic or organic ions.
Par autoru
Dr. Kevin D. Altria ist Wissenschaftler bei der Glaxo Company in Großbritannien.
The author, Dr. Kevin D. Altria, has been working in Glaxo Wellcome R & D for 10 years. During this time he has developed and implemented many routine pharmaceutical analysis CE methods.
The author, Dr. Kevin D. Altria, has been working in Glaxo Wellcome R & D for 10 years. During this time he has developed and implemented many routine pharmaceutical analysis CE methods.
Novērtējiet šo e-grāmatu
Izsakiet savu viedokli!
Informācija lasīšanai
Viedtālruņi un planšetdatori
Instalējiet lietotni Google Play grāmatas Android ierīcēm un iPad planšetdatoriem/iPhone tālruņiem. Lietotne tiks automātiski sinhronizēta ar jūsu kontu un ļaus lasīt saturu tiešsaistē vai bezsaistē neatkarīgi no jūsu atrašanās vietas.
Klēpjdatori un galddatori
Varat klausīties pakalpojumā Google Play iegādātās audiogrāmatas, izmantojot datora tīmekļa pārlūkprogrammu.
E-lasītāji un citas ierīces
Lai lasītu grāmatas tādās elektroniskās tintes ierīcēs kā Kobo e-lasītāji, nepieciešams lejupielādēt failu un pārsūtīt to uz savu ierīci. Izpildiet palīdzības centrā sniegtos detalizētos norādījumus, lai pārsūtītu failus uz atbalstītiem e-lasītājiem.
